BIOFTALMIK is a biotechnology enterprise specialised in the ophthalmology sector, it's main objective is the development, production and commercialisation of diagnosis, prognosis and therapeutic systems for ocular deseases.
BIOFTALMIK investigation is focused on the development of new products for the diagnosis of the ocular surface as well as other deseases such as glaucoma.
Additional investigation on new services for clinical-oftalmology diagnosis are also under investigation.